Population Health Sciences

You are here

Publications

Found 391 results
[ Author(Asc)] Title Type Year
Filters: Biblio is   [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
B
Bishop TF, Ramsay PP, Casalino LP, Bao Y, Pincus HA, Shortell SM.  2016.  Care Management Processes Used Less Often For Depression Than For Other Chronic Conditions In US Primary Care Practices.. Health Aff (Millwood). 35(3):394-400.
Bingham KS, Whyte EM, Mulsant BH, Rothschild AJ, Rudorfer MV, Marino P, Banerjee S, Butters MA, Alexopoulos GS, Meyers BS et al..  2019.  Health-related quality of life in remitted psychotic depression.. J Affect Disord. 256:373-379.
Bingham KS, Dawson DR, Mulsant BH, Banerjee S, Flint AJ.  2020.  Relationships Among History of Psychosis, Cognition and Functioning in Later-Life Remitted Major Depression.. Am J Geriatr Psychiatry.
Bhagwat P, Kapadia SN, Ribaudo HJ, Gulick RM, Currier JS.  2019.  Racial Disparities in Virologic Failure and Tolerability During First-Line HIV Antiretroviral Therapy.. Open Forum Infect Dis. 6(2):ofz022.
Berry K, Pesko MF, Hesdorffer DC, Shellhaas RA, Seirup JK, Grinspan ZM.  2017.  An evaluation of national birth certificate data for neonatal seizure epidemiology.. Epilepsia. 58(3):446-455.
Berg AT, Wusthoff C, Shellhaas RA, Loddenkemper T, Grinspan ZM, Saneto RP, Knupp KG, Patel A, Sullivan JE, Kossoff EH et al..  2019.  Immediate outcomes in early life epilepsy: A contemporary account.. Epilepsy Behav. 97:44-50.
Berg AT, Coryell J, Saneto RP, Grinspan ZM, Alexander JJ, Kekis M, Sullivan JE, Wirrell EC, Shellhaas RA, Mytinger JR et al..  2017.  Early-Life Epilepsies and the Emerging Role of Genetic Testing.. JAMA Pediatr. 171(9):863-871.
Benkeser D, Díaz I, Luedtke A, Segal J, Scharfstein D, Rosenblum M.  2020.  Improving Precision and Power in Randomized Trials for COVID-19 Treatments Using Covariate Adjustment, for Binary, Ordinal, and Time-to-Event Outcomes.. medRxiv.
Benda NC, Veinot TC, Sieck CJ, Ancker JS.  2020.  Broadband Internet Access Is a Social Determinant of Health!. Am J Public Health. 110(8):1123-1125.
Beltran H, Oromendia C, Danila DC, Montgomery B, Hoimes C, Szmulewitz RZ, Vaishampayan U, Armstrong AJ, Stein M, Pinski J et al..  2019.  A Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Patients with Castration-resistant and Neuroendocrine Prostate Cancer: Efficacy and Biomarkers.. Clin Cancer Res. 25(1):43-51.
Behrendt C-A, Kölbel T, Debus ESebastian, Rieß HChristian, Sedrakyan A.  2019.  Reply.. J Vasc Surg. 69(4):1328.
Behrends CN, Paone D, Nolan ML, Tuazon E, Murphy SM, Kapadia SN, Jeng PJ, Bayoumi AM, Kunins HV, Schackman BR.  2019.  Estimated impact of supervised injection facilities on overdose fatalities and healthcare costs in New York City.. J Subst Abuse Treat. 106:79-88.
Behrends CN, Gutkind S, Deming R, Fluegge KR, Bresnahan MP, Schackman BR.  2020.  Impact of Removing Medicaid Fee-for-Service Hepatitis C Virus (HCV) Treatment Restrictions on HCV Provider Experience with Medicaid Managed Care Organizations in New York City.. J Urban Health.
Behrends CN, Eggman AA, Gutkind S, Bresnahan MP, Fluegge K, Laraque F, Litwin AH, Meissner P, Shukla SJ, Perumalswami PV et al..  2019.  A Cost Reimbursement Model for Hepatitis C Treatment Care Coordination.. J Public Health Manag Pract. 25(3):253-261.
Batra JS, Niaz MJunaid, Whang YE, Sheikh A, Thomas C, Christos P, Vallabhajosula S, Jhanwar YS, Molina AM, Nanus DM et al..  2020.  Phase I trial of docetaxel plus lutetium-177-labeled anti-prostate-specific membrane antigen monoclonal antibody J591 (Lu-J591) for metastatic castration-resistant prostate cancer.. Urol Oncol.
Barocas JA, Morgan JR, Fiellin DA, Schackman BR, Yazdi GEftekhari, Stein MD, Freedberg KA, Linas BP.  2019.  Cost-effectiveness of integrating buprenorphine-naloxone treatment for opioid use disorder into clinical care for persons with HIV/hepatitis C co-infection who inject opioids.. Int J Drug Policy.
Barfield E, Deshmukh F, Slighton E, Lentine J, Lu Y, Ma X, Christos PJ, Sockolow RE, Loughlin G, Pillai S.  2020.  Pulmonary Manifestations in Adolescents With Inflammatory Bowel Disease.. Clin Pediatr (Phila). :9922820910821.
Barbour K, Hesdorffer DC, Tian N, Yozawitz EG, McGoldrick PE, Wolf S, McDonough TL, Nelson A, Loddenkemper T, Basma N et al..  2019.  Automated detection of sudden unexpected death in epilepsy risk factors in electronic medical records using natural language processing.. Epilepsia. 60(6):1209-1220.
Bao Y, Maciejewski RC, Garrido MM, Shah MA, Maciejewski PK, Prigerson HG.  2018.  Chemotherapy Use, End-of-Life Care, and Costs of Care Among Patients Diagnosed With Stage IV Pancreatic Cancer.. J Pain Symptom Manage. 55(4):1113-1121.e3.
Bao Y, Druss BG, Jung H-Y, Chan Y-F, Unützer J.  2016.  Unpacking Collaborative Care for Depression: Examining Two Essential Tasks for Implementation.. Psychiatr Serv. 67(4):418-24.
Bao Y, Eggman AA, Richardson JE, Bruce ML.  2014.  Misalignment between medicare policies and depression care in home health care: home health provider perspectives.. Psychiatr Serv. 65(7):905-10.
Bao Y, Eggman AA, Richardson JE, Sheeran TF, Bruce ML.  2015.  Practices of Depression Care in Home Health Care: Home Health Clinician Perspectives.. Psychiatr Serv. 66(12):1365-8.
Bao Y, Pan Y, Taylor A, Radakrishnan S, Luo F, Pincus HAlan, Schackman BR.  2016.  Prescription Drug Monitoring Programs Are Associated With Sustained Reductions In Opioid Prescribing By Physicians.. Health Aff (Millwood). 35(6):1045-51.
Bao Y, Tang Y, Donohue J.  2015.  Retaining Part D's comprehensive coverage of antidepressants: not a silver bullet.. JAMA Psychiatry. 72(3):201-2.
Bao Y, Fan G, Zou D, Wang T, Xue D.  2017.  Patient experience with outpatient encounters at public hospitals in Shanghai: Examining different aspects of physician services and implications of overcrowding.. PLoS One. 12(2):e0171684.